Long COVID in children and adolescents.


Journal

World journal of pediatrics : WJP
ISSN: 1867-0687
Titre abrégé: World J Pediatr
Pays: Switzerland
ID NLM: 101278599

Informations de publication

Date de publication:
10 2021
Historique:
received: 01 07 2021
accepted: 22 08 2021
pubmed: 4 9 2021
medline: 24 11 2021
entrez: 3 9 2021
Statut: ppublish

Résumé

To identify the prevalence and also the full spectrum of symptoms/complaints of children and adolescents who are suffering from long COVID. Furthermore, we investigated the risk factors of long COVID in children and adolescents. All consecutive children and adolescents who were referred to the hospitals anywhere in Fars province, Iran, from 19 February 2020 until 20 November 2020 were included. All patients had a confirmed diagnosis of COVID-19. In a phone call to patients/parents, at least 3 months after their discharge from the hospital, we obtained their current status and information if their parents agreed to participate. In total, 58 children and adolescents fulfilled the inclusion criteria. Twenty-six (44·8%) children/adolescents reported symptoms/complaints of long COVID. These symptoms included fatigue in 12 (21%), shortness of breath in 7 (12%), exercise intolerance in 7 (12%), weakness in 6 (10%), and walking intolerance in 5 (9%) individuals. Older age, muscle pain on admission, and intensive care unit admission were significantly associated with long COVID. Long COVID is a frequent condition in children and adolescents. The scientific community should investigate and explore the pathophysiology of long COVID to ensure that these patients receive appropriate treatments for their condition.

Sections du résumé

BACKGROUND
To identify the prevalence and also the full spectrum of symptoms/complaints of children and adolescents who are suffering from long COVID. Furthermore, we investigated the risk factors of long COVID in children and adolescents.
METHODS
All consecutive children and adolescents who were referred to the hospitals anywhere in Fars province, Iran, from 19 February 2020 until 20 November 2020 were included. All patients had a confirmed diagnosis of COVID-19. In a phone call to patients/parents, at least 3 months after their discharge from the hospital, we obtained their current status and information if their parents agreed to participate.
RESULTS
In total, 58 children and adolescents fulfilled the inclusion criteria. Twenty-six (44·8%) children/adolescents reported symptoms/complaints of long COVID. These symptoms included fatigue in 12 (21%), shortness of breath in 7 (12%), exercise intolerance in 7 (12%), weakness in 6 (10%), and walking intolerance in 5 (9%) individuals. Older age, muscle pain on admission, and intensive care unit admission were significantly associated with long COVID.
CONCLUSIONS
Long COVID is a frequent condition in children and adolescents. The scientific community should investigate and explore the pathophysiology of long COVID to ensure that these patients receive appropriate treatments for their condition.

Identifiants

pubmed: 34478045
doi: 10.1007/s12519-021-00457-6
pii: 10.1007/s12519-021-00457-6
pmc: PMC8414448
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

495-499

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. Children's Hospital, Zhejiang University School of Medicine.

Références

Walitt B, Bartrum E. A clinical primer for the expected and potential post-COVID-19 syndromes. Pain Rep. 2021;6:e887.
doi: 10.1097/PR9.0000000000000887
Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76:399–401.
doi: 10.1136/thoraxjnl-2020-216086
Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626–31.
doi: 10.1038/s41591-021-01292-y
Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199:113–9.
doi: 10.1007/s00408-021-00423-z
Jacobson KB, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, et al. Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. 2021;73:e826–9.
doi: 10.1093/cid/ciab103
Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. (
doi: 10.1007/s00259-021-05215-4
Raveendran AV. Long COVID-19: challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr. 2021;15:145–6.
doi: 10.1016/j.dsx.2020.12.025
https://www.worldometers.info/coronavirus/country/iran/ . Accessed 14 Mar 2021.
Ludvigsson JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021;110:914–21.
doi: 10.1111/apa.15673
Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. “Long-COVID”: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396–8.
doi: 10.1136/thoraxjnl-2020-215818
Batabyal R, Freishtat N, Hill E, Rehman M, Freishtat R, Koutroulis I. Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics. Int J Obes (Lond). 2021;45:1163–9.
doi: 10.1038/s41366-021-00804-7
Mehra B, Aggarwal V, Kumar P, Kundal M, Gupta D, Kumar A, et al. COVID-19-associated severe multisystem inflammatory syndrome in children with encephalopathy and neuropathy in an adolescent girl with the successful outcome: an unusual presentation. Indian J Crit Care Med. 2020;24:1276–8.
doi: 10.5005/jp-journals-10071-23685
García-Salido A, de Carlos Vicente JC, Belda Hofheinz S, Balcells Ramírez J, Slöcker Barrio M, Leóz Gordillo I, et al. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. Crit Care. 2020;24:666.
doi: 10.1186/s13054-020-03332-4
Sterky E, Olsson-Åkefeldt S, Hertting O, Herlenius E, Alfven T, Ryd Rinder M, et al. Persistent symptoms in Swedish children after hospitalisation due to COVID-19. Acta Paediatr. 2021;110:2578–80.
doi: 10.1111/apa.15999
Yoshikawa H, Wuermli AJ, Britto PR, Dreyer B, Leckman JF, Lye SJ, et al. Effects of the Global Coronavirus Disease-2019 pandemic on early childhood development: short- and long-term risks and mitigating program and policy actions. J Pediatr. 2020;223:188–93.
doi: 10.1016/j.jpeds.2020.05.020

Auteurs

Ali A Asadi-Pooya (AA)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. aliasadipooya@yahoo.com.
Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, PA, USA. aliasadipooya@yahoo.com.

Hamid Nemati (H)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Mina Shahisavandi (M)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Ali Akbari (A)

Department of Anesthesiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Amir Emami (A)

Burn & Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Mehrzad Lotfi (M)

Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Mahtab Rostamihosseinkhani (M)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Zohreh Barzegar (Z)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Maryam Kabiri (M)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Zahra Zeraatpisheh (Z)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Mohsen Farjoud-Kouhanjani (M)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Anahita Jafari (A)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Fateme Sasannia (F)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Shayan Ashrafi (S)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Masoume Nazeri (M)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Sara Nasiri (S)

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH